Research Papers:

The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients

Manuel D. Gahete, David Rincón-Fernández, Mario Durán-Prado, Marta Hergueta-Redondo, Alejandro Ibáñez-Costa, Alejandro Rojo-Sebastián, Francisco Gracia-Navarro, Michael D. Culler, Oriol Casanovas, Gema Moreno-Bueno, Raúl M. Luque and Justo P. Castaño _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:60110-60122. https://doi.org/10.18632/oncotarget.11076

Metrics: PDF 1680 views  |   HTML 2637 views  |   ?  


Manuel D. Gahete1,2,3,4,*, David Rincón-Fernández1,2,3,4,*, Mario Durán-Prado2, Marta Hergueta-Redondo5, Alejandro Ibáñez-Costa1,2,3,4, Alejandro Rojo-Sebastián6, Francisco Gracia-Navarro1,2,3,4, Michael D. Culler7, Oriol Casanovas8, Gema Moreno-Bueno5, Raúl M. Luque1,2,3,4,**, Justo P. Castaño1,2,3,4,**

1Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Cordoba, Spain

2Department of Cell Biology, Physiology and Immunology, University of Cordoba, Cordoba, Spain

3Reina Sofia University Hospital (HURS), Cordoba, Spain

4CIBER Physiopathology of Obesity and Nutrition (CIBERobn), Cordoba, Spain

5Department of Biochemistry, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas “Alberto Sols” (CSIC-UAM), IdiPAZ, MD Anderson Internacional Foundation, Madrid, Spain

6Pathology Deparment, MD Anderson Cancer Center, Madrid, Spain

7IPSEN Bioscience, Cambridge, Massachusetts, USA

8Tumor Angiogenesis Group, Catalan Institute of Oncology-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain

*These authors contributed equally to the study and should be considered co-first authors

**These authors co-directed the study and should be considered co-senior authors

Correspondence to:

Justo P. Castaño, email: [email protected]

Raúl M. Luque, email: [email protected]

Keywords: somatostatin receptor, sst5TMD4, breast cancer, angiogenesis, VEGF

Received: May 09, 2016    Accepted: July 19, 2016    Published: August 05, 2016


The truncated somatostatin receptor sst5TMD4 is associated with poor prognosis in breast cancer and increases breast cancer cell malignancy. Here, we examined the cellular/molecular mechanisms underlying this association, aiming to identify new molecular tools to improve diagnosis, prognosis or therapy. A gene expression array comparing sst5TMD4 stably-transfected MCF-7 cells and their controls (empty-plasmid) revealed the existence of profound alterations in the expression of genes involved in key tumoral processes, such as cell survival or angiogenesis. Moreover, sst5TMD4-overexpressing MCF-7 and MDA-MB-231 cells demonstrated increased expression/production of pro-angiogenic factors and enhanced capacity to form mammospheres. Consistently, sst5TMD4-expressing MCF-7 cells induced xenografted tumors with higher VEGF levels and elevated number of blood vessels. Importantly, sst5TMD4 was expressed in a subset of breast cancers, where it correlated with angiogenic markers, lymphatic metastasis, and reduced disease-free survival. These results, coupled to our previous data, support a relevant role of sst5TMD4 in the angiogenic process and reinforce the role of sst5TMD4 in breast cancer malignancy and metastatic potential, supporting its possible utility to develop new molecular biomarkers and drug therapies for these tumors.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11076